Inflammation in ischaemic brain injury: Current advances and future perspectives

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 2, 2010, Pages 253-258

  Xia, Weiliang ^a,b   Han, Jin ^a   Huang, Gang ^c   Ying, Weihai ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Brain injury; Brain ischaemia; Inflammation; Microglia; Peripheral immune system

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CELL ADHESION MOLECULE; CHEMOKINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN S100B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

BRAIN INJURY; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG MECHANISM; ENDOTHELIUM CELL; GLYCATION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MICROGLIA; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; REVIEW; STEM CELL; UNSPECIFIED SIDE EFFECT;

ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CELL ADHESION MOLECULES; CYTOKINES; ENCEPHALITIS; HIGH MOBILITY GROUP PROTEINS; HUMANS; LEUKOCYTES; METALLOENDOPEPTIDASES; MICE; MICROGLIA; MONOCYTES; NADPH OXIDASE; NEURONS; RATS; RECEPTORS, IMMUNOLOGIC; STROKE;

EID: 75649106812     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05279.x     Document Type: Review

References (64)

1. + and NADH in brain functions, brain diseases and brain aging. Front. Biosci. 2007 12 : 1863 1888.
2. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996 27 : 1124 1129.
3. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999 399 (Suppl. A7 14.
4. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke 1998 29 : 705 718.
5. Kriz J. Inflammation in ischemic brain injury: Timing is important. Crit. Rev. Neurobiol. 2006 18 : 145 157.
6. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 2008 14 : 3574 3589.
7. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J. Neuroimmunol. 2007 184 : 53 68.
8. Yilmaz G, Granger DN. Cell adhesion molecules and ischemic stroke. Neurol. Res. 2008 30 : 783 793.
9. Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 1998 56 : 149 171.
10. Planas AM, Gorina R, Chamorro A. Signalling pathways mediating inflammatory responses in brain ischaemia. Biochem. Soc. Trans. 2006 34 : 1267 1270.
11. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 2006 66 : 232 245.
12. Han HS, Yenari MA. Cellular targets of brain inflammation in stroke. Curr. OpInvest. Drugs 2003 4 : 522 529.
13. Patel HC, Boutin H, Allan SM. Interleukin-1 in the brain: Mechanisms of action in acute neurodegeneration. Ann. NY Acad. Sci. 2003 992 : 39 47.
14. Sriram K, O'Callaghan JP. Divergent roles for tumor necrosis factor-alpha in the braJ. Neuroimmune Pharmacol. 2007 2 : 140 153.
15. Froen JF, Munkeby BH, Stray-Pedersen B, Saugstad OD. Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation on perinatal cerebral hypoxia-ischemia. Brain Res. 2002 942 : 87 94.
16. Grilli M, Barbieri I, Basudev H et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur. J. Neurosci. 2000 12 : 2265 2272.
17. Ooboshi H, Ibayashi S, Shichita T et al. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 2005 111 : 913 919. (Pubitemid 40279894)
18. Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: Inflammatory versus neurotrophic aspects. J. Cereb. Blood Flow. Metab. 2009 29 : 464 479.
19. Watanabe H, Abe H, Takeuchi S, Tanaka R. Protective effect of microglial conditioning medium on neuronal damage induced by glutamate. Neurosci. Lett. 2000 289 : 53 6.
20. Hurn PD, Subramanian S, Parker SM et al. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 2007 27 : 1798 1805.
21. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 2006 26 : 654 665.
22. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009 158 : 1098 1111.
23. Klehmet J, Harms H, Richter M et al. Stroke-induced immunodepression and post-stroke infections: Lessons from the Preventive Antibacterial Therapy in Stroke trial. Neuroscience 2009 158 : 1184 1193.
24. Prass K, Meisel C, Hoflich C et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 2003 198 : 725 736.
25. Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: Lessons from animal models. Metab. Brain Dis. 2004 19 : 151 167.
26. Smith CJ, Emsley HC, Gavin CM et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004 4 : 2.
27. Abulafia DP, de Rivero Vaccari JP, Lozano JD, Lotocki G, Keane RW, Dietrich WD. Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J. Cereb. Blood Flow Metab. 2009 29 : 534 544.
28. De Simone R, Ajmone-Cat MA, Minghetti L. Atypical antiinflammatory activation of microglia induced by apoptotic neurons. Possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol. Neurobiol. 2004 29 : 197 212.
29. Lai AY, Todd KG. Microglia in cerebral ischemia. Molecular actions and interactions. Can. J. Physiol. Pharmacol. 2006 84 : 49 59.
30. Shytle RD, Mori T, Townsend K et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 2004 89 : 337 343.
31. Jin D, Liu HX, Hirai H et al. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 2007 446 : 41 5.
32. Dello Russo C, Boullerne AI, Gavrilyuk V, Feinstein DL. Inhibition of microglial inflammatory responses by norepinephrine. Effects on nitric oxide and interleukin-1beta production. J. Neuroinflammation 2004 1 : 9.
33. Carnevale D, De Simone R, Minghetti L. Microglia-neuron interaction in inflammatory and degenerative diseases. Role of cholinergic and noradrenergic systems. CNS Neurol. Disord. Drug Targets 2007 6 : 388 397.
34. Galea E, Feinstein DL. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 1999 13 : 2125 2137.
35. Park HJ, Lee PH, Ahn YW et al. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur. J. Neurosci. 2007 26 : 79 89.
36. Faraco G, Fossati S, Bianchi ME et al. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J. Neurochem. 2007 103 : 590 603.
37. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 2002 72 : 1084 1091.
38. Qiu J, Nishimura M, Wang Y et al. Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 2008 28 : 927 938.
39. Kim JB, Sig Choi J, Yu YM et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic braJ. Neurosci. 2006 26 : 6413 6421.
40. Liu K, Mori S, Takahashi HK et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 2007 21 : 3904 3916.
41. Muhammad S, Barakat W, Stoyanov S et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 2008 28 : 12023 12031.
42. Swanson RA, Ying W, Kauppinen TM. Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 2004 4 : 193 205.
43. Adami C, Bianchi R, Pula G, Donato R. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domaBiochim. Biophys. Acta 2004 1742 : 169 177.
44. Liu L, Li Y, Van Eldik LJ, Griffin WS, Barger SW. S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J. Neurochem. 2005 92 : 546 553.
45. Adami C, Sorci G, Blasi E, Agneletti AL, Bistoni F, Donato R. S100B expression in and effects on microglia. Glia 2001 33 : 131 142.
46. Bianchi R, Giambanco I, Donato R. S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol. Aging 2008 Epub: 1 July 2008; doi :.
47. Ginis I, Jaiswal R, Klimanis D, Liu J, Greenspon J, Hallenbeck JM. TNF-alpha-induced tolerance to ischemic injury involves differential control of NF-kappaB transactivation: The role of NF-kappaB association with p300 adaptor. J. Cereb. Blood Flow Metab. 2002 22 : 142 152.
48. Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 2003 62 : 127 136.
49. Hoehn BD, Palmer TD, Steinberg GK. Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacStroke 2005 36 : 2718 2724.
50. Liu Z, Fan Y, Won SJ et al. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007 38 : 146 152.
51. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003 302 : 1760 1765.
52. Pluchino S, Muzio L, Imitola J et al. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 2008 131 : 2564 2578.
53. Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis: The dual role of microglia. Neuroscience 2009 158 : 1021 1029.
54. Whitney NP, Eidem TM, Peng H, Huang Y, Zheng JC. Inflammation mediates varying effects in neurogenesis: Relevance to the pathogenesis of brain injury and neurodegenerative disorders. J. Neurochem. 2009 108 : 1343 1359.
55. Hirko AC, Dallasen R, Jomura S, Xu Y. Modulation of inflammatory responses after global ischemia by transplanted umbilical cord matrix stem cells. Stem Cells 2008 26 : 2893 2901.
56. Pawate S, Shen Q, Fan F, Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J. Neurosci. Res. 2004 77 : 540 551.
57. Spranger M, Kiprianova I, Krempien S, Schwab S. Reoxygenation increases the release of reactive oxygen intermediates in murine microglia. J. Cereb. Blood Flow Metab. 1998 18 : 670 674.
58. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999 79 : 1431 1568.
59. Mattson MP. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 2005 30 : 883 893.
60. + and NADH in ischemic brain injury. Front. Biosci. 2008 13 : 1141 1151.
61. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic braJ. Cereb. Blood Flow Metab. 2001 21 : 2 14.
62. Rojas S, Martin A, Arranz MJ et al. Imaging brain inflammation with [(11) C]PK11195 by PET and induction of the peripheraL-type benzodiazepine receptor after transient focal ischemia in rats. J. Cereb. Blood Flow Metab. 2007 27 : 1975 1986.
63. Jander S, Schroeter M, Saleh A. Imaging inflammation in acute brain ischemia. Stroke 2007 38 : 642 645.
64. Candelario-Jalil E, Fiebich BL. Cyclooxygenase inhibition in ischemic brain injury. Curr. Pharm. Des. 2008 14 : 1401 1418.